Main content
'Not too late to review cost' of breast cancer drug Kadcyla
The NHS has rejected a drug that can extend lives of women with breast cancer because it is 鈥榯oo expensive鈥�. Jennifer Cozzone head of Health Economics and Pricing at Roche and Mia Rosenblatt from Breast Cancer Campaign discuss.
Duration:
This clip is from
Featured in...
![]()
Health clips
Listen to a selection of clips from recent and upcoming programmes.
More clips from Today
-
![]()
Tim Curry on stardom and life after having a stroke
Duration: 04:41
-
![]()
Badenoch wants PM to address China spy case questions
Duration: 02:50
-
![]()
Freed activist 'doing much better' than expected
Duration: 11:15
-
![]()
The new EU fingerprint travel system - explained
Duration: 06:37
